The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.

MLA

Wang, Xiao-Fei, et al. “The Prognostic Value of Interleukin-17 in Lung Cancer: A Systematic Review with Meta-Analysis Based on Chinese Patients.” PloS One, vol. 12, no. 9, Sept. 2017, p. e0185168. EBSCOhost, https://doi.org/10.1371/journal.pone.0185168.

APA

Wang, X.-F., Zhu, Y.-T., Wang, J.-J., Zeng, D.-X., Mu, C.-Y., Chen, Y.-B., Lei, W., Zhu, Y.-H., & Huang, J.-A. (2017). The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients. PloS One, 12(9), e0185168. https://doi.org/10.1371/journal.pone.0185168

Chicago

Wang, Xiao-Fei, Yi-Tong Zhu, Jia-Jia Wang, Da-Xiong Zeng, Chuan-Yong Mu, Yan-Bin Chen, Wei Lei, Ye-Han Zhu, and Jian-An Huang. 2017. “The Prognostic Value of Interleukin-17 in Lung Cancer: A Systematic Review with Meta-Analysis Based on Chinese Patients.” PloS One 12 (9): e0185168. doi:10.1371/journal.pone.0185168.